Evidence map›Paper›PMID 39816080›Full record

ArticleNarra J2024

Early activation of macrophage-2 with IL-4 in stromal vascular fraction increases VEGF levels and adipocyte count and maintains volume of fat graft in Wistar rats (

Rachel Vania, I Gph Sanjaya, Agus Rrh Hamid, Shita D Sudarsa, I Gasm Dewi, I W Niryana, Elysanti D Martadiani

Abstract read
In one paragraph

Article in Narra J, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rachel VaniaDivision of Plastic Reconstructive and Aesthetic Surgery, Faculty of Medicine, Universitas Udayana, Denpasar, Indonesia.
I Gph SanjayaDivision of Plastic Reconstructive and Aesthetic Surgery, Faculty of Medicine, Universitas Udayana, Denpasar, Indonesia.
Agus Rrh HamidDivision of Plastic Reconstructive and Aesthetic Surgery, Faculty of Medicine, Universitas Udayana, Denpasar, Indonesia.
Shita D SudarsaDivision of Plastic Reconstructive and Aesthetic Surgery, Faculty of Medicine, Universitas Udayana, Denpasar, Indonesia.
I Gasm DewiDepartment of Pathological Anatomy, Faculty of Medicine, Universitas Udayana, Denpasar, Indonesia.
I W NiryanaDepartment of Neurosurgery, Faculty of Medicine, Universitas Udayana, Denpasar, Indonesia.
Elysanti D MartadianiDepartment of Radiology, Faculty of Medicine, Universitas Udayana, Denpasar, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several previous studies have demonstrated the benefits of early macrophage 2 activation fat grafts supplemented with macrophage culture. However, this approach is considered impractical in clinical settings because of intraperitoneal induction use. The aim of this study was to investigate the effect of early stromal vascular fraction (SVF) macrophage-2 activation with IL-4 on fat graft survival compared to SVF alone using an animal model for better fat graft viability. This experimental study included inguinal fat harvesting, isolated with collagenases to retrieve the SVF, and then injected with a combination of fat graft and SVF (0.3 mL) into the scalp region. The intervention group received an IL-4 intralesional injection on the third day, and the fat grafts were biopsied on days 7, 14, and The primary outcomes were the final volume of the fat graft, vascular endothelial growth factor (VEGF) expression, and the adipocyte cell count using perilipin staining on immunohistochemistry examination. The group receiving IL-4 exhibited significantly higher VEGF on days 7, 14, and 30 (

Indexed as

AdipocytesAdipose TissueInterleukin-4MacrophagesStromal Vascular FractionVascular Endothelial Growth Factor AAnimalsGraft SurvivalMacrophage ActivationMaleRatsRats, WistarInterleukin-4Vascular Endothelial Growth Factor AadipocytesFat graftinterleukin-4macrophagesregeneration

Identifiers

PMID39816080
PMCPMC11731649

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.